NAOV实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	15 902.00
平均成交量	60 407.00
市值	2.11M
EPS	$0 ( 2024-04-01 )
下一个收益日期	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.360
ATR14	$0.0120 (1.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Mika Thomas	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Jacob Harold	Buy	6 667	Option to Purchase Common Stock
2024-01-23	Schroeder Maria	Buy	16 667	Option to Purchase Common Stock
2024-01-23	Ferguson Michael	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Goldstein Martin M	Buy	16 667	Option to Purchase Common Stock

INSIDER POWER
29.17
Last 97 transactions
Buy: 2 103 083 \| Sell: 846 526

Nanovibronix Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Nanovibronix Inc 财务报表

Annual	2023
营收:	$2.28M
毛利润:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2023
营收:	$2.28M
毛利润:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2022
营收:	$752 000
毛利润:	$167 000 (22.21 %)
EPS:	$-3.84

FY	2021
营收:	$1.70M
毛利润:	$770 000 (45.43 %)
EPS:	$-0.570

Financial Reports:

No articles found.

Nanovibronix Inc

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.